Ac-225 Labeled Targeted Radiopharmaceuticals in Clinical Trials
Actinium-225 (Ac-225), 136Ac89, is an important radioisotope in nuclear medicine with applications in the targeted alpha therapy (TAT) in oncology. Ac-225 contains 89 protons and 136 Neutrons, corresponding to atomic mass